Combining data-driven design and parallel chemistry for macrocycle development

all companies
milestones

Founded 2017

Partnered 2019

Team

Cameron Pye

Josh Schwochert

Board
LEAD INVESTOR
category
Oncology
Cardiopulmonary + Metabolic

Drugging the 'undruggable' by developing safe and more effective therapeutics that combine the benefits of small and large molecule therapeutics

No items found.